NantKwest Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 171

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

NantKwest General Information

Description

Developer of immunotherapy agents designed to use natural killer cells to treat cancer, infectious diseases and inflammatory conditions. The company offers activated and engineered natural killer cell therapies with different targeting mechanisms, enabling healthcare providers and researchers to treat immune-related diseases through cell-based approaches.

Contact Information

Website
www.nantkwest.com
Formerly Known As
Conkwest
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9920 Jefferson Boulevard
  • Culver City, CA 90232
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Acquirer
ImmunityBio
Vertical(s)
Manufacturing, Digital Health, Life Sciences, Oncology
Corporate Office
  • 9920 Jefferson Boulevard
  • Culver City, CA 90232
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NantKwest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 09-Mar-2021 Completed Generating Revenue
9. 2PO 25-Jun-2020 Completed Generating Revenue
8. Secondary Transaction - Open Market 01-Jun-2017 Completed Generating Revenue
7. Secondary Transaction - Open Market 17-Apr-2017 Completed Generating Revenue
6. IPO 28-Jul-2015 Completed Generating Revenue
5. Later Stage VC 16-Jul-2015 Completed Generating Revenue
4. Later Stage VC (Series A) 26-Dec-2014 Completed Clinical Trials - General
3. Later Stage VC 16-Apr-2014 Completed Clinical Trials - General
2. Later Stage VC 01-Jan-2010 Completed Startup
1. Accelerator/Incubator Completed Startup
To view NantKwest’s complete valuation and funding history, request access »

NantKwest Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapy agents designed to use natural killer cells to treat cancer, infectious diseases and inflamma
Drug Discovery
Culver City, CA
171 As of 2020

San Diego, CA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NantKwest Competitors (59)

One of NantKwest’s 59 competitors is Rakuten Medical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rakuten Medical Venture Capital-Backed San Diego, CA
Cogent Biosciences Formerly VC-backed Waltham, MA
IFM Therapeutics Venture Capital-Backed Boston, MA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 59 competitors. Get the full list »

NantKwest Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NantKwest Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avoro Capital Venture Capital Minority
Bonderman Family Limited Corporation Minority
Cambridge Equities Corporation Minority
Foley Ventures Venture Capital Minority
Foresite Capital Growth/Expansion Minority
You’re viewing 5 of 10 investors. Get the full list »

NantKwest Investments & Acquisitions (3)

NantKwest’s most recent deal was a Reverse Merger with ImmunityBio for . The deal was made on 08-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ImmunityBio 08-Mar-2021 Reverse Merger Drug Discovery
Viracta Therapeutics 12-Feb-2019 Later Stage VC Drug Discovery
Viracta Therapeutics 04-Apr-2017 Later Stage VC Drug Discovery
To view NantKwest’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

NantKwest ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view NantKwest’s complete esg history, request access »

NantKwest FAQs

  • When was NantKwest founded?

    NantKwest was founded in 2002.

  • Where is NantKwest headquartered?

    NantKwest is headquartered in Culver City, CA.

  • What is the size of NantKwest?

    NantKwest has 171 total employees.

  • What industry is NantKwest in?

    NantKwest’s primary industry is Drug Discovery.

  • Is NantKwest a private or public company?

    NantKwest is a Private company.

  • What is NantKwest’s current revenue?

    The current revenue for NantKwest is .

  • How much funding has NantKwest raised over time?

    NantKwest has raised $401M.

  • Who are NantKwest’s investors?

    Avoro Capital, Bonderman Family Limited, Cambridge Equities, Foley Ventures, and Foresite Capital are 5 of 10 investors who have invested in NantKwest.

  • Who are NantKwest’s competitors?

    Rakuten Medical, Cogent Biosciences, IFM Therapeutics, Inovio Pharmaceuticals, and Sorrento Therapeutics are some of the 59 competitors of NantKwest.

  • When was NantKwest acquired?

    NantKwest was acquired on 09-Mar-2021.

  • Who acquired NantKwest?

    NantKwest was acquired by ImmunityBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process